UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058815
Receipt number R000067259
Scientific Title An intervention study to evaluate the efficacy of combined DHA and vitamin D supplementation on bone metabolism in healthy participants
Date of disclosure of the study information 2026/03/31
Last modified on 2025/08/16 18:57:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of test foods containing DHA and vitamin D on bone in healthy participants

Acronym

The effects of DHA and vitamin D intake on bone in healthy participants

Scientific Title

An intervention study to evaluate the efficacy of combined DHA and vitamin D supplementation on bone metabolism in healthy participants

Scientific Title:Acronym

An intervention study on the efficacy of combined supplementation with DHA and vitamin D on bone metabolism in healthy participants

Region

Japan


Condition

Condition

None

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effects of consuming test foods containing DHA and vitamin D on bone metabolites in healthy women.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Vitamin D metabolites
Bone metabolic markers

Key secondary outcomes

Bone density
Blood characteristics
Subjective health perception


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Consumption of test foods
(4 weeks each in summer and winter)

Interventions/Control_2

Consumption of test foods
(4 weeks each in summer and winter)

Interventions/Control_3

Consumption of test foods
(4 weeks each in summer and winter)

Interventions/Control_4

Consumption of test foods
(4 weeks each in summer and winter)

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >

Gender

Female

Key inclusion criteria

1) Directly employed by Fuji Oil Co., Ltd. and able to visit the health management office on the day of blood sampling
2) Written consent for participation in the study has been obtained from the participant
3) Able to communicate in Japanese

Key exclusion criteria

1)Individuals currently taking DHA or EPA
2)Individuals currently taking vitamin D
3)Individuals who regularly consume vitamin D-fortified foods (e.g., egg yolks)
4)Individuals using medications containing vitamin D due to skin conditions
5)Individuals currently receiving medication for osteoporosis prescribed by a physician
6)Individuals who have experienced abnormal symptoms such as feeling unwell or a drop in blood pressure during or after blood collection.
7)Other individuals deemed ineligible for this study by an occupational physician.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Ichinose

Organization

Fuji Oil Co., Ltd.

Division name

Research Institute for Creating the Future

Zip code

300-2497

Address

4-3 Kinunodai, Tsukubamirai, Ibaraki, Japan.

TEL

0297-52-6325

Email

ichinose.takashi@so.fujioil.co.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Ichinose

Organization

Fuji Oil Co., Ltd.

Division name

Research Institute for Creating the Future

Zip code

300-2497

Address

4-3 Kinunodai, Tsukubamirai, Ibaraki, Japan.

TEL

0297-52-6325

Homepage URL


Email

ichinose.takashi@so.fujioil.co.jp


Sponsor or person

Institute

Fuji Oil Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Osaka Metropolitan University
JEOL Ltd.

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization

Fuji Oil IRB

Address

4-3 Kinunodai, Tsukubamirai, Ibaraki, Japan.

Tel

0297-52-6325

Email

nakano.mikio@so.fujioil.co.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2025-05

Org. issuing International ID_1

Research Ethics Committee, School of Human Life and Ecology, Osaka Metropolitan University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

不二製油株式会社(大阪府)


Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 07 Month 01 Day

Date of IRB

2025 Year 07 Month 02 Day

Anticipated trial start date

2025 Year 08 Month 22 Day

Last follow-up date

2026 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 08 Month 16 Day

Last modified on

2025 Year 08 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067259